![](https://investorshub.advfn.com/uicon/602751.png?cb=1523775966)
Tuesday, February 23, 2021 6:57:36 AM
Just imagine the headlines for a positive USRM decision. It will be seen as a massive win beating the FDA even though the game isn't over. Optimism over the future of the stem cell business model will change.
I expect the 11th Circuit Court to RR this case. The CA case and Judge Bernal's decision to move forward with a trial - a case that mirrors USRM's to a "T" - cannot be ignored. The Appellate Court must be keenly aware of its significance. Bernal set a precedent by rejecting a summary judgment.
A favorable ruling moves things to the 4th quarter. I expect more dilution and silence after the run while we await the trial. I also see a new type of investor moving in...
Things will cool down until a decision. Up - down - flat - then ??? The good news in this scenario is that there will be a trial and another decision. The market likes knowing what is round the corner.
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM